GGrantIndex
← Leaderboards

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center

Torrance, CA

Compare ↔
$281,526,140
Total funding
739
Grants

Funding over time

peak $36.8M · FY2006–25
$50M$37.5M$25M$12.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$265,896,335 · 726
DOD$9,970,736 · 6
CDC$4,855,437 · 4
FDA$703,632 · 2
AHRQ$100,000 · 1

By mechanism

R01$129,456,272 · 79
M01$35,446,140 · 509
N01$24,617,493 · 12
U01$19,210,290 · 8
R21$15,023,047 · 38
—$9,970,736 · 6

Investigators at Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Amir Sheikhi$2,144,1223 gr2Nicholas Jendzjowsky$1,488,9693 gr3Eiji Yoshihara$1,203,4681 gr4Hua Wang$920,0301 gr5Lina R. Nih$468,3601 gr6Logan Nickels$390,3471 gr7Catalina Maria Guerra$128,5001 gr

Emerging Leaders

6–10 yrs in

1Soula Athanasia Danopoulos$3,528,2322 gr2Harry B Rossiter$3,136,0572 gr3Marc Swidergall$2,993,6263 gr4Priya Uppuluri$2,863,9394 gr5Rie Sakai-Bizmark$877,1162 gr6Alessandra Adami$824,2981 gr7Tim Cooke$590,6491 gr8Merritt Schreiber$441,0551 gr

All-Time

Most funded here, all years

1Scott G Filler$16,719,24613 gr2Ashraf S. Ibrahim$16,537,60310 gr3Patricia I Dickson$8,715,21212 gr4Michael R Yeaman$5,421,6546 gr5Mark Goodarzi$4,107,6653 gr6Chrisandra Lee Shufelt$3,607,7701 gr7Soula Athanasia Danopoulos$3,528,2322 gr8Harry B Rossiter$3,136,0572 gr

Largest grants

Construction - Chronic Disease Clinical Research Center$9,711,810
C06 · FY2010 · RR
GENERAL CLINICAL RESEARCH CENTER$7,948,729
M01 · FY2006 · RR
General Clinical Research Center$7,612,858
M01 · FY2008 · RR
General Clinical Research Center$7,612,858
M01 · FY2009 · RR
General Clinical Research Center$7,612,858
M01 · FY2010 · RR
General Clinical Research Center$4,658,836
M01 · FY2007 · RR
IND-ENABLEMENT OF KINOCIDIN GAMMA-RP-1 FOR MDR GRAM-NEGATIVE INFECTIONS$4,423,425
· FY2020 · Defense Health Agency
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE$3,252,953
N01 · FY2020 · HD
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE$3,083,340
N01 · FY2015 · HD
ULTRA-EARLY SURGERY FOR ACUTE SPINAL CORD INJURY: A PROSPECTIVE TRIAL OF TIMING OF SURGICAL DECOMPRESSION$2,966,875
· FY2024 · Defense Health Agency
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE$2,832,062
N01 · FY2023 · HD
Systems Epigenomics of Persistent Bloodstream Infection$2,344,235
U19 · FY2024 · AI
Systems Epigenomics of Persistent Bloodstream Infection$2,326,682
U19 · FY2025 · AI
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE$2,321,712
N01 · FY2022 · HD
Systems Epigenomics of Persistent Bloodstream Infection$2,304,639
U19 · FY2023 · AI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection$2,291,458
U01 · FY2018 · AI
Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk stratification, Diagnosis and Management of the Disease$2,205,213
P01 · FY2025 · AI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection$1,999,922
U01 · FY2016 · AI
ADD FUNDING IN THE AMOUNT OF 657257.81$1,979,058
· FY2012 · Department of Defense
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection$1,962,994
U01 · FY2019 · AI